AIRLINK 213.50 Increased By ▲ 3.95 (1.88%)
BOP 10.47 Increased By ▲ 0.01 (0.1%)
CNERGY 7.29 Decreased By ▼ -0.06 (-0.82%)
FCCL 34.54 Increased By ▲ 0.15 (0.44%)
FFL 18.59 Increased By ▲ 0.54 (2.99%)
FLYNG 23.26 Increased By ▲ 0.34 (1.48%)
HUBC 131.65 Decreased By ▼ -0.84 (-0.63%)
HUMNL 14.25 Increased By ▲ 0.11 (0.78%)
KEL 5.10 Increased By ▲ 0.07 (1.39%)
KOSM 7.22 Increased By ▲ 0.15 (2.12%)
MLCF 45.12 Decreased By ▼ -0.08 (-0.18%)
OGDC 220.50 Increased By ▲ 2.12 (0.97%)
PACE 7.69 Increased By ▲ 0.11 (1.45%)
PAEL 42.40 Increased By ▲ 0.70 (1.68%)
PIAHCLA 17.52 Increased By ▲ 0.22 (1.27%)
PIBTL 8.73 Increased By ▲ 0.18 (2.11%)
POWERPS 12.50 No Change ▼ 0.00 (0%)
PPL 189.98 Increased By ▲ 0.95 (0.5%)
PRL 42.40 Increased By ▲ 0.07 (0.17%)
PTC 25.70 Increased By ▲ 0.53 (2.11%)
SEARL 103.65 Decreased By ▼ -0.31 (-0.3%)
SILK 1.05 Increased By ▲ 0.02 (1.94%)
SSGC 41.06 Increased By ▲ 1.82 (4.64%)
SYM 19.30 Increased By ▲ 0.14 (0.73%)
TELE 9.38 Increased By ▲ 0.14 (1.52%)
TPLP 12.95 Decreased By ▼ -0.15 (-1.15%)
TRG 69.93 Increased By ▲ 0.75 (1.08%)
WAVESAPP 10.70 Decreased By ▼ -0.02 (-0.19%)
WTL 1.71 No Change ▼ 0.00 (0%)
YOUW 4.22 Increased By ▲ 0.08 (1.93%)
BR100 12,189 Increased By 109.9 (0.91%)
BR30 36,895 Increased By 292.1 (0.8%)
KSE100 116,880 Increased By 827.3 (0.71%)
KSE30 36,844 Increased By 266.1 (0.73%)

Martin Klizan pulled out another come-from-behind showpiece to win his fourth career title on Sunday with a 6-7 (1/7), 6-3, 6-1 defeat of Gael Monfils in the Rotterdam World Tennis final. The swashbuckling world number 43 from Slovakia came into the final having saved eight match points in his previous clashes against Roberto Bautista Agut and Nicolas Mahut.
Klizan becomes the first Slovak to win the Dutch event, while fifth seeded French star Monfils now stands 5-18 in career finals.
World number 18 Monfils, whose last title was two years ago in Montpellier, looked to be in a winning position as he claimed the opening set in a tiebreaker after an hour on court.

Copyright Agence France-Presse, 2016

Comments

Comments are closed.